These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17646722)

  • 21. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
    Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
    Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
    Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8).
    Pozzilli P; Crinò A; Schiaffini R; Manfrini S; Fioriti E; Coppolino G; Pitocco D; Visalli N; Corbi S; Spera S; Suraci C; Cervoni M; Matteoli MC; Patera IP; Ghirlanda G;
    Diabetes Technol Ther; 2003; 5(6):965-74. PubMed ID: 14709198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of insulin pump therapy: mealtime delivery is the key factor.
    Crawford LM; Sinha RN; Odell RM; Comi RJ
    Endocr Pract; 2000; 6(3):239-43. PubMed ID: 11421538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Pediatric Type 1 Diabetes: A Meta-Analysis and Prospective Cohort Study.
    Wang X; Zhao X; Chen D; Zhang M; Gu W
    Front Endocrinol (Lausanne); 2021; 12():608232. PubMed ID: 33737909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal insulin requirements on continuous subcutaneous insulin infusion during the first 12 months after diagnosis of type 1 diabetes mellitus.
    Ramchandani N; Ellis MK; Jain S; Bhandari S; Anhalt H; Maclaren NK; Ten S
    J Diabetes Sci Technol; 2010 May; 4(3):610-4. PubMed ID: 20513327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in parental involvement in the care of children and adolescents with type 1 diabetes mellitus on multiple daily insulin injections versus continuous subcutaneous insulin infusion.
    Cemeroglu AP; Timmer S; Turfe Z; Davis AT; Koehler TJ; Can A; Kleis L; Daniel MS
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):265-72. PubMed ID: 26630689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty.
    Cemeroglu AP; Thomas JP; Zande LT; Nguyen NT; Wood MA; Kleis L; Davis AT
    Endocr Pract; 2013; 19(5):805-11. PubMed ID: 23757622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of Continuous Subcutaneous Insulin Infusion Pump Therapy During Five Years of Treatment on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus.
    Korkmaz Ö; Demir G; Çetin H; Mecidov İ; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):147-152. PubMed ID: 29537377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective.
    Mack-Fogg JE; Orlowski CC; Jospe N
    Pediatr Diabetes; 2005 Mar; 6(1):17-21. PubMed ID: 15787897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
    Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
    Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus.
    Liberatore R; Perlman K; Buccino J; Artiles-Sisk A; Daneman D
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):223-6. PubMed ID: 15055358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
    Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
    Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment and long-term follow-up of patients diagnosed with type 1 diabetes mellitus before age 5.
    Ata A; Er E; Evin F; Işıklar H; Abdullayev N; Demir G; Özen S; Altınok YA; Darcan Ş; Gökşen D
    J Pediatr Endocrinol Metab; 2021 Feb; 34(2):201-207. PubMed ID: 33544547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.
    Hathout EH; McClintock T; Sharkey J; Kytsenko D; Hartwick N; Hadley-Scofield M; Torgeson S; Mace JW
    Diabetes Technol Ther; 2003; 5(2):175-81. PubMed ID: 12871607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.